Glycosylation and processing of pro-B-type natriuretic peptide in cardiomyocytes

Biochemical and Biophysical Research Communications

Volumn 411, Issue 3, 2011, Pages 593-598

  Peng, Jianhao ^a   Jiang, Jingjing ^a   Wang, Wei ^a   Qi, Xiaofei ^a,b   Sun, Xue Long ^c   Wu, Qingyu ^a,b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c CLEVELAND STATE UNIVERSITY   (United States)

Author keywords

BNP; Cardiomyocytes; Corin; Furin; Glycosylation; Pro BNP

Indexed keywords

ALANINE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ARGININE; CARBOHYDRATE; CORIN; FURIN; GLYCAN; GLYCOSIDASE; LYSINE; MEMBRANE PROTEIN; THREONINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CONTROLLED STUDY; GENE MUTATION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPRECIPITATION; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; WESTERN BLOTTING; WILD TYPE;

FURIN; GLYCOSIDE HYDROLASES; GLYCOSYLATION; HEK293 CELLS; HUMANS; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; SERINE ENDOPEPTIDASES;

MURINAE;

EID: 79961128693     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.192     Document Type: Article

References (38)

1. Daniels L.B., Maisel A.S. Natriuretic peptides. Journal of the American College of Cardiology 2007, 50:2357-2368.
2. Goetze J.P. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Clinical Chemistry 2004, 50:1503-1510.
3. Mair J. Biochemistry of B-type natriuretic peptide--where are we now?. Clinical Chemistry and Laboratory Medicine 2008, 46:1507-1514.
4. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., Omland T., Storrow A.B., Abraham W.T., Wu A.H., Clopton P., Steg P.G., Westheim A., Knudsen C.W., Perez A., Kazanegra R., Herrmann H.C., McCullough P.A. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. New England Journal of Medicine 2002, 347:161-167.
5. Wu Q., Xu-Cai Y.O., Chen S., Wang W. Corin: new insights into the natriuretic peptide system. Kidney International 2009, 75:142-146.
6. Sawada Y., Suda M., Yokoyama H., Kanda T., Sakamaki T., Tanaka S., Nagai R., Abe S., Takeuchi T. Stretch-induced hypertrophic growth of cardiocytes and processing of brain-type natriuretic peptide are controlled by proprotein-processing endoprotease furin. Journal of Biological Chemistry 1997, 272:20545-20554.
7. Semenov A.G., Tamm N.N., Seferian K.R., Postnikov A.B., Karpova N.S., Serebryanaya D.V., Koshkina E.V., Krasnoselsky M.I., Katrukha A.G. Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases. Clinical Chemistry 2010, 56:1166-1176.
8. Wang W., Liao X., Fukuda K., Knappe S., Wu F., Dries D.L., Qin J., Wu Q. Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity. Circulation Research 2008, 103:502-508.
9. Yan W., Wu F., Morser J., Wu Q. Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:8525-8529.
10. Steiner D.F., Smeekens S.P., Ohagi S., Chan S.J. The new enzymology of precursor processing endoproteases. Journal of Biological Chemistry 1992, 267:23435-23438.
11. Pan J., Hinzmann B., Yan W., Wu F., Morser J., Wu Q. Genomic structures of the human and murine corin genes and functional GATA elements in their promoters. Journal of Biological Chemistry 2002, 277:38390-38398.
12. Wu Q. The serine protease corin in cardiovascular biology and disease. Frontiers in bioscience: a journal and virtual library 2007, 12:4179-4190.
13. Yan W., Sheng N., Seto M., Morser J., Wu Q. Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. Journal of Biological Chemistry 1999, 274:14926-14935.
14. Boerrigter G., Costello-Boerrigter L.C., Harty G.J., Lapp H., Burnett J.C. Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 2007, 292:R897-901.
15. Brandt I., Lambeir A.M., Ketelslegers J.M., Vanderheyden M., Scharpe S., De Meester I. Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form. Clinical Chemistry 2006, 52:82-87.
16. Crimmins D.L., Kao J.L. A glycosylated form of the human cardiac hormone pro B-type natriuretic peptide is an intrinsically unstructured monomeric protein. Archives of Biochemistry and Biophysics 2008, 475:36-41.
17. Jiang J., Pristera N., Wang W., Zhang X., Wu Q. Effect of sialylated O-glycans in pro-brain natriuretic peptide stability. Clinical Chemistry 2010, 56:959-966.
18. Liang F., O'Rear J., Schellenberger U., Tai L., Lasecki M., Schreiner G.F., Apple F.S., Maisel A.S., Pollitt N.S., Protter A.A. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. Journal of the American College of Cardiology 2007, 49:1071-1078.
19. Mair J. Clinical significance of pro-B-type natriuretic peptide glycosylation and processing. Clinical Chemistry 2009, 55:394-397.
20. Schellenberger U., O'Rear J., Guzzetta A., Jue R.A., Protter A.A., Pollitt N.S. The precursor to B-type natriuretic peptide is an O-linked glycoprotein. Archives of Biochemistry and Biophysics 2006, 451:160-166.
21. Semenov A.G., Postnikov A.B., Tamm N.N., Seferian K.R., Karpova N.S., Bloshchitsyna M.N., Koshkina E.V., Krasnoselsky M.I., Serebryanaya D.V., Katrukha A.G. Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site. Clinical Chemistry 2009, 55:489-498.
22. Claycomb W.C., Lanson N.A., Stallworth B.S., Egeland D.B., Delcarpio J.B., Bahinski A., Izzo N.J. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:2979-2984.
23. Wu C., Wu F., Pan J., Morser J., Wu Q. Furin-mediated processing of pro-C-type natriuretic peptide. Journal of Biological Chemistry 2003, 278:25847-25852.
24. Knappe S., Wu F., Madlansacay M.R., Wu Q. Identification of domain structures in the propeptide of corin essential for the processing of proatrial natriuretic peptide. Journal of Biological Chemistry 2004, 279:34464-34471.
25. Liao X., Wang W., Chen S., Wu Q. Role of glycosylation in corin zymogen activation. Journal of Biological Chemistry 2007, 282:27728-27735.
26. Kuan S.F., Byrd J.C., Basbaum C., Kim Y.S. Inhibition of mucin glycosylation by aryl-N-acetyl-alpha-galactosaminides in human colon cancer cells. Journal of Biological Chemistry 1989, 264:19271-19277.
27. Eklund E.A., Freeze H.H. Essentials of glycosylation. Semin Pediatr Neurol 2005, 12:134-143.
28. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993, 3:97-130.
29. Dong N., Chen S., Yang J., He L., Liu P., Zhen D., Li L., Zhou Y., Ruan C., Plow E., Wu Q. Plasma soluble corin in patients with heart failure. Circulation and Heart Failure 2010, 3:207-211.
30. Dong N., Dong J., Liu P., Xu L., Shi S., Wu Q. Effects of anticoagulants on human plasma soluble corin levels measured by ELISA. Clinica Chimica Acta 2010, 411:1998-2003.
31. Ibebuogu U.N., Gladysheva I.P., Houng A.K., Reed G.L. Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic Peptide. Circulation and Heart Failure 2011, 4:114-120.
32. Ichiki T., Huntley B.K., Heublein D.M., Sandberg S.M., McKie P.M., Martin F.L., Jougasaki M., Burnett J.C. Corin is present in the normal human heart, kidney, and blood, with pro-B-type natriuretic peptide processing in the circulation. Clinical Chemistry 2011, 57:40-47.
33. Jiang J., Wu S., Wang W., Chen S., Peng J., Zhang X., Wu Q. Ectodomain shedding and autocleavage of the cardiac membrane protease corin. Journal of Biological Chemistry 2011, 286:10066-10072.
34. Peleg A., Jaffe A.S., Hasin Y. Enzyme-linked immunoabsorbent assay for detection of human serine protease corin in blood. Clinica Chimica Acta 2009, 409:85-89.
35. Knappe S., Wu F., Masikat M.R., Morser J., Wu Q. Functional analysis of the transmembrane domain and activation cleavage of human corin. Journal of Biological Chemistry 2003, 278:52363-52370.
36. Niederkofler E.E., Kiernan U.A., O'Rear J., Menon S., Saghir S., Protter A.A., Nelson R.W., Schellenberger U. Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure. Circulation and Heart Failure 2008, 1:258-264.
37. Chen S., Sen S., Young D., Wang W., Moravec C.S., Wu Q. Protease corin expression and activity in failing hearts. American journal of physiology. Heart andcirculatory physiology 2010, 299:H1687-1692.
38. Tran K.L., Lu X., Lei M., Feng Q., Wu Q. Upregulation of corin gene expression in hypertrophic cardiomyocytes and failing myocardium. American journal of physiology. Heart andcirculatory physiology 2004, 287:H1625-1631.